LetterClinicoEconomics and outcomes research : CEORPublished
Economic Impact of Elranatamab for Treatment of Patients with Relapsed or Refractory Multiple Myeloma [Letter]
Regional connection
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
- Institution
- Johnson & Johnson
- County
- Montgomery County
Publication record
- Type
- Letter
- Venue
- ClinicoEconomics and outcomes research : CEOR
- Published
- Topic
- Clinical care
- PubMed ID
- 40756255
- PubMed Central ID
- PMC12318513
- Open access
- Yes, open
- Added to directory
- Source checked